The development of innovative new drugs is of time-consuming, expensive, and risky process.
Despite these challenges, the pharmaceuticol industry has been remarkably successful in developing a broad range of important new medicines.
This report examines several aspects of new drug development in the pharmaceutical industry and provides a quantitative evaluation of the role of the drug industry in medical progress.
Results indicate that of the 196 new chemical entities approved by the FDA from 2 982 through 2 990, the source of 92% was the pharmaceutical industry.
Mots-clés Pascal : Industrie pharmaceutique, Recherche développement, Médicament, 1980-1990, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Pharmaceutical industry, Research and development, Drug, 1980-1990, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0462104
Code Inist : 002B30A08. Création : 199406.